10-60084779-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_020987.5(ANK3):​c.3897G>A​(p.Thr1299Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00153 in 1,592,418 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 6 hom. )

Consequence

ANK3
NM_020987.5 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.32

Publications

4 publications found
Variant links:
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
  • intellectual disability-hypotonia-spasticity-sleep disorder syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • intellectual disability
    Inheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 10-60084779-C-T is Benign according to our data. Variant chr10-60084779-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 434172.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.32 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00109 (166/152226) while in subpopulation NFE AF = 0.00185 (126/68024). AF 95% confidence interval is 0.00159. There are 0 homozygotes in GnomAd4. There are 69 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 6 AR,Unknown,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANK3NM_020987.5 linkc.3897G>A p.Thr1299Thr synonymous_variant Exon 32 of 44 ENST00000280772.7 NP_066267.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANK3ENST00000280772.7 linkc.3897G>A p.Thr1299Thr synonymous_variant Exon 32 of 44 1 NM_020987.5 ENSP00000280772.1

Frequencies

GnomAD3 genomes
AF:
0.00107
AC:
163
AN:
152108
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000435
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.0000945
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00185
Gnomad OTH
AF:
0.000960
GnomAD2 exomes
AF:
0.00114
AC:
266
AN:
232346
AF XY:
0.00126
show subpopulations
Gnomad AFR exome
AF:
0.000633
Gnomad AMR exome
AF:
0.000583
Gnomad ASJ exome
AF:
0.000110
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000142
Gnomad NFE exome
AF:
0.00191
Gnomad OTH exome
AF:
0.00161
GnomAD4 exome
AF:
0.00157
AC:
2264
AN:
1440192
Hom.:
6
Cov.:
31
AF XY:
0.00156
AC XY:
1113
AN XY:
714780
show subpopulations
African (AFR)
AF:
0.000520
AC:
17
AN:
32704
American (AMR)
AF:
0.000697
AC:
28
AN:
40152
Ashkenazi Jewish (ASJ)
AF:
0.0000394
AC:
1
AN:
25374
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39214
South Asian (SAS)
AF:
0.000964
AC:
79
AN:
81942
European-Finnish (FIN)
AF:
0.000283
AC:
15
AN:
52942
Middle Eastern (MID)
AF:
0.00281
AC:
16
AN:
5684
European-Non Finnish (NFE)
AF:
0.00181
AC:
1996
AN:
1102706
Other (OTH)
AF:
0.00188
AC:
112
AN:
59474
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
111
223
334
446
557
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00109
AC:
166
AN:
152226
Hom.:
0
Cov.:
32
AF XY:
0.000927
AC XY:
69
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.000433
AC:
18
AN:
41546
American (AMR)
AF:
0.000392
AC:
6
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5180
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4816
European-Finnish (FIN)
AF:
0.0000945
AC:
1
AN:
10586
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00185
AC:
126
AN:
68024
Other (OTH)
AF:
0.000950
AC:
2
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
8
17
25
34
42
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00141
Hom.:
0
Bravo
AF:
0.00106
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jun 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ANK3: BP4, BP7 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Oct 31, 2016
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
4.1
DANN
Benign
0.71
PhyloP100
-1.3
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150367434; hg19: chr10-61844537; COSMIC: COSV55065796; COSMIC: COSV55065796; API